← Home
Broader market sell-offs are driven by escalating U.S. tariffs, trade war fears, and recession concerns, causing investor uncertainty, global supply chain disruptions, and sharp declines in major stock indices.
GSK Plc’s U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of optimism about sales of its new drugs. The British drugs giant said it expects 2031 revenue to be more than 40 billion pounds
Stock Swings
Price Drops
-6.64% 2025-04-08Price Hikes
+8.46% closed: 2025-02-07GSK Plc’s U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of optimism about sales of its new drugs. The British drugs giant said it expects 2031 revenue to be more than 40 billion pounds
Wait! There's more — sign up for free or log in